Michele Bartoletti

15PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Health informatics and information systemsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 16, 2026
PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study.

|Nov 28, 2025
The future of gynecologic oncologic surgery: a narrative review of current surgical trials.

Stefano Fucina, Claudio Reato, Anna Del Fabro

|Nov 26, 2025
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer.

Riccardo Vida, Michele Bartoletti, Lucia Lerda

|Sep 26, 2025
Leveraging Real-World Data From a Clinicogenomic Database Addresses the Treatment Gap in Patients With High-Grade Serous Ovarian Cancer.

Chiara Maura Ciniselli, Elena Conca, Michele Bartoletti

|Nov 13, 2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity.

Anna Nespolo, Linda Stefenatti, Ilenia Pellarin

|May 27, 2023
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.

Giovanni Canil, Marco Orleni, Bianca Posocco

Pageof 3

Frequent Collaborators

5 joint publications

Vincenzo Canzonieri

4 joint publications

Fabio Puglisi

2 joint publications

Francesco Perrone

2 joint publications

Gustavo Baldassarre